180 related articles for article (PubMed ID: 27119092)
1. Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles.
Autio K; Knuuttila A; Kipar A; Pesonen S; Guse K; Parviainen S; Rajamäki M; Laitinen-Vapaavuori O; Vähä-Koskela M; Kanerva A; Hemminki A
Mol Ther Oncolytics; 2014; 1():14002. PubMed ID: 27119092
[TBL] [Abstract][Full Text] [Related]
2. Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs.
Béguin J; Gantzer M; Farine I; Foloppe J; Klonjkowski B; Maurey C; Quéméneur É; Erbs P
Sci Rep; 2021 Jan; 11(1):2209. PubMed ID: 33500518
[TBL] [Abstract][Full Text] [Related]
3. Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs.
Béguin J; Nourtier V; Gantzer M; Cochin S; Foloppe J; Balloul JM; Laloy E; Tierny D; Klonjkowski B; Quemeneur E; Maurey C; Erbs P
BMC Vet Res; 2020 Aug; 16(1):307. PubMed ID: 32843040
[TBL] [Abstract][Full Text] [Related]
4. Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs.
LeBlanc AK; Naik S; Galyon GD; Jenks N; Steele M; Peng KW; Federspiel MJ; Donnell R; Russell SJ
Hum Gene Ther Clin Dev; 2013 Dec; 24(4):174-81. PubMed ID: 24219832
[TBL] [Abstract][Full Text] [Related]
5. Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles.
Autio KP; Ruotsalainen JJ; Anttila MO; Niittykoski M; Waris M; Hemminki A; Vähä-Koskela MJ; Hinkkanen AE
BMC Vet Res; 2015 Jul; 11():170. PubMed ID: 26215394
[TBL] [Abstract][Full Text] [Related]
6. Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma.
Chintala NK; Choe JK; McGee E; Bellis R; Saini JK; Banerjee S; Moreira AL; Zauderer MG; Adusumilli PS; Rusch VW
Front Immunol; 2023; 14():1112960. PubMed ID: 36875061
[TBL] [Abstract][Full Text] [Related]
7. Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.
Patil SS; Gentschev I; Adelfinger M; Donat U; Hess M; Weibel S; Nolte I; Frentzen A; Szalay AA
PLoS One; 2012; 7(10):e47472. PubMed ID: 23091626
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours.
Hwang CC; Igase M; Sakurai M; Haraguchi T; Tani K; Itamoto K; Shimokawa T; Nakaichi M; Nemoto Y; Noguchi S; Coffey M; Okuda M; Mizuno T
Vet Comp Oncol; 2018 Jun; 16(2):229-238. PubMed ID: 29076241
[TBL] [Abstract][Full Text] [Related]
9. Intensive ocular sampling for the detection of subclinical canine herpesvirus-1 shedding in dogs with experimentally-induced latent infection.
Ledbetter EC; Spertus CB; Diel DG; Dubovi EJ
Vet Microbiol; 2021 Mar; 254():109001. PubMed ID: 33540209
[TBL] [Abstract][Full Text] [Related]
10. The effect of topical ocular corticosteroid administration in dogs with experimentally induced latent canine herpesvirus-1 infection.
Ledbetter EC; Kice NC; Matusow RB; Dubovi EJ; Kim SG
Exp Eye Res; 2010 Jun; 90(6):711-7. PubMed ID: 20223234
[TBL] [Abstract][Full Text] [Related]
11. First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells.
Minev BR; Lander E; Feller JF; Berman M; Greenwood BM; Minev I; Santidrian AF; Nguyen D; Draganov D; Killinc MO; Vyalkova A; Kesari S; McClay E; Carabulea G; Marincola FM; Butterfield LH; Szalay AA
J Transl Med; 2019 Aug; 17(1):271. PubMed ID: 31426803
[TBL] [Abstract][Full Text] [Related]
12. Frequency of spontaneous canine herpesvirus-1 reactivation and ocular viral shedding in latently infected dogs and canine herpesvirus-1 reactivation and ocular viral shedding induced by topical administration of cyclosporine and systemic administration of corticosteroids.
Ledbetter EC; da Silva EC; Kim SG; Dubovi EJ; Schwark WS
Am J Vet Res; 2012 Jul; 73(7):1079-84. PubMed ID: 22738061
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies.
Autio K; Knuuttila A; Kipar A; Ahonen M; Parviainen S; Diaconu I; Kanerva A; Hakonen T; Vähä-Koskela M; Hemminki A
Vet Comp Oncol; 2016 Dec; 14(4):395-408. PubMed ID: 25302859
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent Tagged Vaccinia Virus Genome Allows Rapid and Efficient Measurement of Oncolytic Potential and Discovery of Oncolytic Modulators.
Gallardo F; Schmitt D; Brandely R; Brua C; Silvestre N; Findeli A; Foloppe J; Top S; Kappler-Gratias S; Quentin-Froignant C; Morin R; Lagarde JM; Bystricky K; Bertagnoli S; Erbs P
Biomedicines; 2020 Nov; 8(12):. PubMed ID: 33256205
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma.
Andtbacka RHI; Amatruda T; Nemunaitis J; Zager JS; Walker J; Chesney JA; Liu K; Hsu CP; Pickett CA; Mehnert JM
EBioMedicine; 2019 Sep; 47():89-97. PubMed ID: 31409575
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy.
Gómez A; Sardón D; Cejalvo T; Vázquez F; García-Castro J; Perisé-Barrios AJ
Mol Ther Oncolytics; 2020 Sep; 18():525-534. PubMed ID: 32995478
[TBL] [Abstract][Full Text] [Related]
17. Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma.
MacNeill AL; Weishaar KM; Séguin B; Powers BE
Viruses; 2018 Jul; 10(8):. PubMed ID: 30060548
[TBL] [Abstract][Full Text] [Related]
18. Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas.
Petrov I; Gentschev I; Vyalkova A; Elashry MI; Klymiuk MC; Arnhold S; Szalay AA
Viruses; 2020 Jul; 12(7):. PubMed ID: 32664672
[TBL] [Abstract][Full Text] [Related]
19. Association between nasal shedding and fever that influenza A (H3N2) induces in dogs.
Song D; Moon H; Jung K; Yeom M; Kim H; Han S; An D; Oh J; Kim J; Park B; Kang B
Virol J; 2011 Jan; 8():1. PubMed ID: 21205327
[TBL] [Abstract][Full Text] [Related]
20. Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter.
Haddad D; Chen CH; Carlin S; Silberhumer G; Chen NG; Zhang Q; Longo V; Carpenter SG; Mittra A; Carson J; Au J; Gonen M; Zanzonico PB; Szalay AA; Fong Y
PLoS One; 2012; 7(8):e41647. PubMed ID: 22912675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]